Janus Health: The Payer Contract Intelligence Platform for Health Systems

The platform's differentiation rests on a claim that most RCM vendors cannot make credibly: that a single intelligence layer can connect what happens at patient access, what happens on the claims floor, and why individual staff performance varies — and surface all three in one coherent workflow. Whether that promise holds up in production depends on integration depth, data quality, and how aggressively a health system drives adoption. The sections below break each dimension down in terms RCM VPs can take directly into a vendor evaluation.

The Landscape: Contract Analytics In 2026

Payer contract management has historically been one of the most under-resourced functions in health system revenue cycle. Most organizations can tell you their posted contract rates but cannot reliably tell you whether they were actually paid those rates on any given claim, nor can they systematically identify which payer, which DRG grouping, or which service line is generating the most systematic underpayment. A 2024 HFMA analysis found that the average health system writes off or fails to recover between 1% and 3% of net patient revenue annually due to underpayment and contractual disputes — on a $500M net revenue health system, that range represents $5M to $15M in recoverable dollars.

The market has responded with a wave of payer contract intelligence tools, but most were designed as standalone analytics layers that require separate data ingestion, separate staff training, and separate workflow management. Health systems end up with dashboards nobody checks because the workflow lives in the EHR and the insight lives somewhere else. Janus Health's embedded model attempts to solve exactly that gap — by pushing intelligence directly into Epic workflows where staff already live, rather than asking them to toggle between systems to act on what the analytics surface.

The regulatory environment adds urgency. CMS-0057-F, finalized January 17, 2024, requires that impacted payers — including Medicare Advantage organizations, Medicaid managed care plans, CHIP plans, and qualified health plans on the Federally Facilitated Exchanges — implement FHIR-based prior authorization APIs by January 1, 2027. This fundamentally changes the PA workflow landscape — systems that have built manual or semi-automated PA processes around portal-based submissions will need to retool. Simultaneously, Medicare Advantage enrollment now exceeds half of all Medicare beneficiaries, and CMS's Notice of Admission requirements for MA plans have teeth: a missed or untimely NOA can result in the payer withholding the entire inpatient claim payment. These two regulatory pressure points together create a strong structural argument for access automation investment in the immediate term.

How The Platform Works: Janusiq

JanusIQ is organized into three named performance engines, each targeting a distinct phase of the revenue cycle. AccessIQ handles pre-service and patient access, AccelerateIQ targets claims and AR management, and AdaptiveIQ addresses team performance and operational optimization. The architecture is intentional — Janus designed the three engines to share a common data layer so that patterns identified in claims performance can inform upstream access interventions, and workforce intelligence from AdaptiveIQ can be linked to downstream claim outcomes.

AccessIQ covers prior authorization submission and tracking, Notice of Admission automation, and fax-to-Epic referral conversion. The referral automation feature is tactically underappreciated: an estimated 75% of specialist referrals in community health systems still arrive via fax, and manually re-entering fax content into Epic orders is a low-value, error-prone task that consumes meaningful FTE capacity. JanusIQ's AI converts faxed referrals into Epic orders directly, eliminating that re-entry step. The vendor claims this automation alone saves staff up to five hours per day — that figure represents a notable FTE impact when aggregated across a mid-size health system's patient access team, and should be validated against your actual referral intake volume during pilot evaluation.

AccelerateIQ focuses on the claims and AR side, automating claims status checking across payer portals and driving denial workflow management with root cause analytics. Manual payer portal checking is one of the most persistent productivity drains in hospital AR departments — a typical AR specialist at a 400-bed health system may spend two to three hours per day navigating individual payer portals to check claim status, time that produces no additional cash and exists only because payers do not proactively communicate claim status. AccelerateIQ automates that portal activity and surfaces denial reasons with actionable follow-up prioritization rather than simply generating a denial report.

AdaptiveIQ is the most distinctive component strategically. Most RCM automation platforms tell you what happened — denial rate, days in AR, clean claim rate. AdaptiveIQ adds a behavioral data layer that tells you why performance varies across teams and individuals, and guides staff toward the highest-impact work. This positions JanusIQ not just as an automation tool but as a management intelligence platform — something a VP of Revenue Cycle can use in staff reviews, capacity planning, and training decisions. The combination of process data and outcome data in one view is uncommon in the RCM vendor landscape.

Where It Delivers Value

The clearest, most immediately quantifiable ROI case for JanusIQ comes from the NOA automation module within AccessIQ. CMS requires timely Notice of Admission submission for Medicare Advantage inpatient stays under the MA plan's participation requirements, and the penalty for non-compliance is not a fine — it is payment withholding on the underlying inpatient claim. For a DRG with an average reimbursement of $15,000 to $25,000, a single missed NOA represents a full claim at risk. Health systems with high MA inpatient volume and manual NOA processes have documented write-offs directly attributable to untimely submissions. Automating this single workflow has a P&L impact that can be modeled directly from your MA inpatient volume and average claim value — it is one of the few RCM automation investments where the downside risk of inaction is precisely calculable.

The prior authorization automation within AccessIQ operates in a more crowded competitive space but benefits from favorable regulatory tailwinds. CMS-0057-F requires impacted payers to implement FHIR-based PA decision APIs by January 1, 2027, which will enable real-time PA status communication — and in conjunction with the Prior Authorization Support (PAS) implementation guide, near-real-time adjudication — at a scale not previously achievable. Health systems that have already integrated PA automation infrastructure through a platform like JanusIQ will be positioned to connect to those APIs as they come online, rather than scrambling to build or procure API connectivity after the mandate deadline. The operational value is real today — eliminated manual submission tasks, reduced PA cycle time, lower denial rates on PA-required procedures — and the strategic value compounds as the API infrastructure matures.

On the claims side, AccelerateIQ's denial workflow automation delivers value proportional to your current denial rate and your team's capacity to work denials effectively. MGMA and HFMA benchmarking consistently shows that health systems with initial denial rates above 10% recover a meaningful share of that revenue when they implement systematic denial root cause analysis and prioritized follow-up workflows. The specific percentage improvement JanusIQ delivers has not been published by the vendor with numeric precision, which is a gap in the ROI documentation that buyers should address directly in the sales process — asking for case-study level data from comparable health systems before contract execution.

Competitive Positioning

JanusIQ competes in adjacent ways against several distinct categories of vendor. In denial automation, Waystar is the dominant incumbent, with deep payer connectivity and a large installed base in hospital billing. Waystar's denial management capabilities are mature, but Waystar does not offer the access-layer or performance-intelligence components that JanusIQ packages together — a health system using Waystar still needs separate tools for PA automation and staff performance analytics. In prior authorization specifically, Infinx has built a strong position combining technology with offshore PA staffing, and Epic's own CoverCheck module competes for Epic-native health systems that want a single-vendor approach.

The strategic differentiation Janus is making is architectural: rather than owning one layer deeply, JanusIQ covers the full cycle with enough depth at each layer to reduce the number of vendor relationships a health system manages. For a CFO trying to simplify the RCM vendor stack, that consolidation narrative is compelling. For an RCM VP who evaluates each capability individually, the question is whether JanusIQ's depth at each layer matches or exceeds best-in-class point solutions — and that answer will vary by health system depending on which pain points are most acute.

Against nThrive, Strata Decision Technology, and Craneware — the platforms most commonly referenced in health system CFO conversations — JanusIQ occupies a different position. Strata and Craneware are financial planning and cost accounting tools; they analyze contract value and service line margin but do not automate operational workflows. nThrive has historically focused on coding, revenue integrity analytics, and patient financial communications. JanusIQ is operationally focused — it acts on the workflow, not just the analysis. A health system that already uses Strata for contract modeling and nThrive for coding intelligence may find that JanusIQ fills the operational execution gap those platforms leave open, rather than replacing them.

Vendor	Primary Strength	Access Automation	Claims/AR	Performance Analytics	EHR Embedded
JanusIQ (Janus Health)	Full-cycle operational intelligence	Yes (PA, NOA, referral)	Yes (portal, denials)	Yes (AdaptiveIQ)	Yes (Epic confirmed)
Waystar	Denial automation, payer connectivity	Limited	Strong	Limited	Partial
Infinx	PA automation + staffing	Strong	Limited	No	Partial
nThrive	Revenue integrity, coding, patient financial	No	Moderate	Limited	No
Strata Decision Technology	Financial planning, contract modeling	No	No	Financial only	No
Epic (native modules)	EHR-native workflow	CoverCheck (PA)	Limited	No	Native

The 7 Powers Lens: Janus Health Strategic Durability

The 7 Powers framework, developed by Hamilton Helmer, is the most useful strategic lens for RCM buyers evaluating vendor durability — not because it is abstract theory but because it forces a concrete question: what prevents a competitor from replicating this product and eroding your vendor's advantage over the three-to-five-year period your contract will be in place? For health systems signing multi-year SaaS agreements with RCM vendors, understanding where a vendor's moat is real versus where it is marketing language determines whether you are buying a durable partnership or a capability that will be commoditized by an EHR vendor before your contract term ends.

Power	Strength	Assessment
Scale Economies	Weak	Private company, no disclosed customer volume; AI model improvement with data scale is plausible but not independently verified
Network Economies	Weak	Platform does not generate value from multi-party network effects; payer connectivity is bilateral, not networked
Counter-Positioning	Moderate	Three-engine full-cycle model is difficult for pure-play point solutions to replicate without M&A; Epic is structurally unlikely to build a behavioral team performance and management coaching layer
Switching Costs	Strong	EHR-embedded workflows, staff behavioral data, and denial root cause history create high switching friction once adoption is established
Branding	Weak	No publicly named health system clients; brand equity not yet established at scale
Cornered Resource	Weak	No disclosed exclusive data partnerships or payer agreements that would constitute a defensible proprietary asset
Process Power	Emerging	The combination of access + claims + performance in one embedded workflow is a process architecture competitors cannot quickly replicate; requires operational depth to execute

Switching Costs: The Real Moat

Switching costs are Janus Health's most credible durable advantage, and RCM buyers should understand exactly what drives them. Once JanusIQ is embedded in Epic workflows and staff are navigating denials, PA submissions, and referral intake through the platform's interface, the organizational muscle memory of how work gets done becomes tied to JanusIQ's workflow logic. The AdaptiveIQ behavioral data layer compounds this: the historical record of team performance, individual productivity patterns, and denial root cause trends accumulates over time in a format that cannot be transferred to a replacement system. That institutional data is effectively held by Janus once two or more contract cycles pass. For buyers, this means the first contract negotiation is the most important one — negotiate aggressively on price, performance guarantees, and data portability terms before switching costs accrue.

Counter-Positioning: The Three-Engine Advantage

Counter-positioning is the second meaningful power in Janus Health's arsenal, though it is still emerging rather than established. The argument is this: Waystar cannot easily add a behavioral team performance layer to their denial platform without fundamentally repositioning as a management tool, which conflicts with their core identity as a payment accuracy engine. Infinx cannot add full AccelerateIQ and AdaptiveIQ capabilities without diluting their PA-plus-staffing business model. Epic can add individual automation modules natively but is structurally unlikely to build a team performance intelligence and management coaching tool — that is not how EHR vendors make money. JanusIQ's three-engine model occupies a space that each individual competitor has a structural reason not to fully replicate. That is the definition of counter-positioning, and it is worth taking seriously in your vendor evaluation.

Switching Cost Reality for Buyers

Buyers entering a JanusIQ agreement should negotiate three specific protections before signing. First, require data portability guarantees in the contract — specifically that denial root cause history, performance analytics data, and workflow configuration can be exported in a machine-readable format. Second, negotiate annual renewal options rather than multi-year auto-renew terms during the first contract cycle, preserving leverage until the platform has demonstrated measurable outcomes at your system. Third, require that integration credentials and EHR configuration documentation are owned by your organization, not held solely by Janus Health — this prevents a hostage situation if the vendor relationship deteriorates or the company is acquired.

Implementation Experience

JanusIQ's EHR-embedded architecture is described by the vendor as requiring no infrastructure overhaul — a claim that is plausible for Epic shops with active API frameworks but should be tested carefully for health systems on Oracle Health (Cerner), Meditech, or CPSI. The vendor has confirmed Epic integration via the fax-to-Epic referral automation feature, which requires Epic API access and workflow configuration. For health systems that have not fully activated Epic's third-party API framework — or that have IT governance processes requiring security review for new API integrations — the timeline to "results from day one" will be longer than the vendor's standard positioning suggests.

A realistic implementation timeline for a 300-to-500-bed health system with an active Epic environment and a cooperative IT team is eight to twelve weeks from contract execution to full workflow activation across all three engines. That estimate assumes clean claims data, available IT resources for API configuration, and active participation from both patient access and AR team leads in workflow training. Health systems with fragmented data environments, multiple hospital entities with different EHR configurations, or IT departments managing competing priorities should budget twelve to sixteen weeks and plan a phased rollout — AccessIQ first, then AccelerateIQ, then AdaptiveIQ — rather than attempting simultaneous activation.

Staff adoption is the most common failure mode for RCM automation platforms, and JanusIQ's AdaptiveIQ layer creates a specific organizational dynamic worth managing carefully: staff members whose productivity is being measured and surfaced to management may resist adoption if the implementation is framed as surveillance rather than support. The change management narrative matters. Health systems that have successfully implemented performance intelligence tools in RCM position them as coaching and workload-balancing tools — surfacing why a team member's denial recovery rate is low so that training can be targeted, rather than using the data punitively. How leadership frames AdaptiveIQ at go-live will significantly affect adoption velocity.

Pricing And Roi Analysis

Janus Health has not published pricing on its public website, which is standard practice for enterprise SaaS vendors in the health system market. Based on the platform's architecture and target market profile — hospitals and health systems with existing Epic infrastructure — the pricing model is consistent with enterprise RCM SaaS pricing that typically runs on a per-bed, per-provider, or percentage-of-net-revenue basis. Health systems evaluating JanusIQ should request an itemized pricing structure for each engine (AccessIQ, AccelerateIQ, AdaptiveIQ) separately, even if Janus Health proposes bundled platform pricing, to maintain leverage for scoped deployment.

The ROI case for a health system should be modeled on three distinct streams. First, the NOA automation impact: calculate your current Medicare Advantage inpatient volume, identify the percentage of encounters where NOA submissions are currently manual, and apply your documented rate of late or missed submissions against your average MA inpatient claim value. This calculation produces a concrete recoverable revenue number that belongs on the first page of your internal business case. Second, the FTE capacity impact from AccessIQ's referral automation and claims status automation — the five-hours-per-day figure the vendor cites should be stress-tested against your actual referral intake volume and AR portal-checking time, then converted to FTE equivalents at your local labor cost. Third, the denial recovery improvement from AccelerateIQ, which requires baseline denial rate data and an assumption about recovery improvement percentage — ask the vendor for a comparable health system case study that documents starting and ending denial rates to calibrate this assumption honestly.

ROI Stream	Calculation Driver	Data You Need	Vendor Claim
NOA Automation	MA inpatient volume × late NOA rate × avg claim value	Your MA census, current NOA compliance rate	Full claim value recovery on previously withheld payments
FTE Capacity (Access)	Staff hours saved × loaded labor cost	Referral intake and portal-check time logs	Up to 5 hours/day per staff member
Denial Recovery	Denial rate reduction × net revenue at risk	Starting denial rate, denial write-off rate	Net Revenue Improvement (specific % not published)
Prior Auth Efficiency	PA cycle time reduction × PA-required procedure volume	PA cycle time baseline, staff hours per PA	Reduced manual submission tasks